Stimuli‐Responsive PROTACs for Controlled Protein Degradation
Angewandte Chemie International Edition · 25.09.2023 · 62 (39)
DOI: 10.1002/anie.202306824 ↗Kurz gefasst
Fachartikel in der Zeitschrift Angewandte Chemie International Edition, online erschienen am 17.08.2023. Verfasst von Keli An und 16 weiteren Autor:innen. Beteiligte Einrichtung: The Key Laboratory of Biomedical Information Engineering of the Ministry of Education, School of Life Science and Technology, Bioinspired Engineering…. Hauptthemen laut MEDLINE: Neoplasms. Die Arbeit wurde bisher 98-mal zitiert (Crossref) und nennt 53 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Key Technologies Research and Development Program.
Abstract (Originalsprache)
Proteolysis Targeting Chimeras (PROTACs) represent a promising therapeutic modality to address undruggable and resistant issues in drug discovery. However, potential on‐target toxicity remains clinically challenging. We developed a generalized caging strategy to synthesize a series of stimuli‐responsive PROTACs (sr‐PROTACs) with diverse molecular blocks bearing robust and cleavable linkers, presenting “turn on” features in manipulating protein degradation. By leveraging pathological cues, such as elevated ROS, phosphatase, H 2 S, or hypoxia, and external triggers, such as ultraviolet light, X‐Ray, or bioorthogonal reagents, we achieved site‐specific activation and traceless release of original PROTACs through de‐caging and subsequent self‐immolative cleavage, realizing selective uptake and controlled protein degradation in vitro. An in vivo study revealed that two sr‐PROTACs with phosphate‐ and fluorine‐containing cages exhibited high solubility and long plasma exposure, which were specifically activated by tumor overexpressing phosphatase or low dosage of X‐Ray irradiation in situ, leading to efficient protein degradation and potent tumor remission. With more reactive biomarkers to be screened from clinical practice, our caging library could provide a general tool to design activatable PROTACs, prodrugs, antibody‐drug conjugates, and smart biomaterials for personalized treatment, tissue engineering or regenerative medicine.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Key Laboratory of Biomedical Information Engineering of the Ministry of Education, School of Life Science and Technology, Bioinspired Engineering and Biomechanics Center (BEBC), Xi'an Jiaotong University, Xi'an, 710…
- Zhejiang Cancer Hospital, The Key Laboratory of Zhejiang Province for Aptamers and Theranostics, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, 310022, China.
- College of Material, Chemistry and Chemical Engineering, Hangzhou Normal University, Hangzhou, 311121, China.
- Department of Gastrointestinal Surgery, The Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, 210008, China.
- School of Aerospace Engineering, Tsinghua University, Beijing, 100084, China.
ORCID-Profile: Penghui Zhang, Feng Xu, Weihong Tan
Förderung
- National Natural Science Foundation of China
- Key Technologies Research and Development Program
Zitieren
APA
An, K., Deng, X., Chi, H., Zhang, Y., Li, Y., Cheng, M., Ni, Z., Yang, Z., Wang, C., Chen, J., Bai, J., Ran, C., Wei, Y., Li, J., Zhang, P., Xu, F., & Tan, W. (2023). Stimuli‐Responsive PROTACs for Controlled Protein Degradation. Angewandte Chemie International Edition, 62(39). https://doi.org/10.1002/anie.202306824
Vancouver
An K, Deng X, Chi H, Zhang Y, Li Y, Cheng M, et al. Stimuli‐Responsive PROTACs for Controlled Protein Degradation. Angewandte Chemie International Edition. 2023;62(39). doi:10.1002/anie.202306824
BibTeX
@article{An2023,
author = {An, Keli and Deng, Xuqian and Chi, Hongli and Zhang, Yuchao and Li, Yan and Cheng, Ming and Ni, Zhigang and Yang, Zhi and Wang, Chao and Chen, Jinling and Bai, Jianbo and Ran, Chunyan and Wei, Yong and Li, Juan and Zhang, Penghui and Xu, Feng and Tan, Weihong},
title = {Stimuli‐Responsive PROTACs for Controlled Protein Degradation},
journal = {Angewandte Chemie International Edition},
year = {2023},
volume = {62},
number = {39},
doi = {10.1002/anie.202306824}
}
EUVIMED